Related Experiment Video
Updated: Apr 26, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
23.7K
[Hepatitis C infection in children].
Vibeke Brix Christensen1, Sannie Nordly, Bjørn Fischler
1Gl. Strandvej 97, 3050 Humlebæk. brixchr@dadlnet.dk.
Ugeskrift for Laeger
|August 7, 2014
Summary
Chronic hepatitis C (HCV) affects 2-3% globally. Early antiviral treatment in children shows results comparable to adults, despite potential long-term risks like cirrhosis.
Area of Science:
- Hepatology
- Pediatric Infectious Diseases
- Virology
Background:
- Chronic hepatitis C virus (HCV) infection impacts 2-3% of the global population.
- Vertical transmission of HCV occurs in approximately 5% of cases.
- Current evidence does not support breastfeeding abstinence or Cesarean delivery to prevent HCV transmission.
Purpose of the Study:
- To review the natural history of HCV infection in children.
- To evaluate the benefits of early antiviral treatment in pediatric HCV cases.
- To compare treatment outcomes in children versus adults.
Main Methods:
- Literature review of pediatric HCV infection.
- Analysis of natural history data in children.
- Assessment of antiviral treatment efficacy (pegylated interferon and ribavirin) in pediatric populations.
Main Results:
- HCV infection in children is generally benign in the short term.
- Potential long-term complications include liver cirrhosis and hepatocellular carcinoma.
- Pediatric patients demonstrate comparable response rates to antiviral therapy as adults, with treatment duration varying by genotype.
Conclusions:
- Early treatment of HCV in children with pegylated interferon and ribavirin may be beneficial.
- Treatment outcomes in children are similar to those observed in adult patients.
- Monitoring for long-term complications remains important in pediatric HCV cases.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.2K
10:25"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
13.1K
Related Concept Videos
01:25Hepatitis
78
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
78
01:28Viral Hepatitis I: Introduction
18
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
18
01:27Cytomegalovirus Disease
94
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
94
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
405
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
399
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
399
01:25Immunodeficiency Diseases
3.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
3.4K